Zobrazeno 1 - 10
of 20 088
pro vyhledávání: '"paclitaxel (Taxol)"'
Autor:
Ahire, Chetan1,2 (AUTHOR), Nyul‐Toth, Adam1,2,3,4 (AUTHOR), DelFavero, Jordan1,2 (AUTHOR), Gulej, Rafal1,2 (AUTHOR), Faakye, Janet A.1,2 (AUTHOR), Tarantini, Stefano1,2,3,5,6 (AUTHOR), Kiss, Tamas2,7 (AUTHOR), Kuan‐Celarier, Anna2,6 (AUTHOR), Balasubramanian, Priya1,2,6 (AUTHOR), Ungvari, Anna1,2,3 (AUTHOR), Tarantini, Amber1,2,3,6 (AUTHOR), Nagaraja, Raghavendra2 (AUTHOR), Yan, Feng8 (AUTHOR), Tang, Qinggong8 (AUTHOR), Mukli, Peter1,2,3 (AUTHOR), Csipo, Tamas2,3 (AUTHOR), Yabluchanskiy, Andriy1,2,5,6 (AUTHOR), Campisi, Judith9 (AUTHOR), Ungvari, Zoltan1,2,3,5,6 (AUTHOR) zoltan-ungvari@ouhsc.edu, Csiszar, Anna1,2,3,6 (AUTHOR) anna‐csiszar@ouhsc.edu
Publikováno v:
Aging Cell. Jul2023, Vol. 22 Issue 7, p1-15. 15p.
Autor:
Sparreboom, Alex, Van Asperen, Judith, Mayer, Ulrich, Schinkel, Alfred H., Smit, Johan W., Borst, Piet, Nooijen, Willem J., Beijnen, Jos H., Van Tellingen, Olaf
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 1997 Mar 01. 94(5), 2031-2035.
Externí odkaz:
https://www.jstor.org/stable/41580
Autor:
Wimalasiri, V. W.1 (AUTHOR), Dunuweera, S. P.1,2 (AUTHOR), Dunuweera, A. N.3 (AUTHOR), Rajapakse, R. M. G.1,2 (AUTHOR)
Publikováno v:
BioMed Research International. 5/10/2021, p1-8. 8p.
Publikováno v:
BMC Ophthalmology, Vol 20, Iss 1, Pp 1-4 (2020)
Abstract Background Paclitaxel (PTX) is an antineoplastic drug widely used in treatments for ovarian, breast, and small-cell lung cancer. Although ocular effects associated with PTX have been previously described, very few studies have specifically r
Externí odkaz:
https://doaj.org/article/2431cc9000d84936847ebb68fc3195fb
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 1995 Jul . 92(15), 6920-6924.
Externí odkaz:
https://www.jstor.org/stable/2367765
Autor:
Chetan Ahire, Adam Nyul‐Toth, Jordan DelFavero, Rafal Gulej, Janet A. Faakye, Stefano Tarantini, Tamas Kiss, Anna Kuan‐Celarier, Priya Balasubramanian, Anna Ungvari, Amber Tarantini, Raghavendra Nagaraja, Feng Yan, Qinggong Tang, Peter Mukli, Tamas Csipo, Andriy Yabluchanskiy, Judith Campisi, Zoltan Ungvari, Anna Csiszar
Publikováno v:
Aging Cell.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd590f794b87e732b133ed1cd0a0f4b1
https://doi.org/10.1111/acel.13832
https://doi.org/10.1111/acel.13832
Autor:
Zanville, Noah Robert
Indiana University-Purdue University Indianapolis (IUPUI)
The purpose of this prospective, observational study was to determine if a technique used to detect early signs of small-fiber neuropathy (local skin heating) could detect signs of small-
The purpose of this prospective, observational study was to determine if a technique used to detect early signs of small-fiber neuropathy (local skin heating) could detect signs of small-
Externí odkaz:
https://hdl.handle.net/1805/17116
Autor:
John Oluwafemi Teibo, Chioma Ejiro Irozuru, Titilade Kehinde Ayandeyi Teibo, Olabode Ebenezer Omotoso, Ahmad O. Babalghith, Gaber El-Saber Batiha
Publikováno v:
Drug Repurposing-Advances, Scopes and Opportunities in Drug Discovery
Paclitaxel (Taxol) is potent natural anticancer drug that has evolved over the years. It has been useful in the management of many cancers. Hence, this review aims to appraise the pros and cons of paclitaxel in the management of cancers using literat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2336ed134b2fc59b5c70b42246bb1113
https://mts.intechopen.com/articles/show/title/perspective-chapter-appraisal-of-paclitaxel-taxol-pros-and-cons-in-the-management-of-cancer-prospect
https://mts.intechopen.com/articles/show/title/perspective-chapter-appraisal-of-paclitaxel-taxol-pros-and-cons-in-the-management-of-cancer-prospect